Skip to main content
. 2018 Dec 3;18:610. doi: 10.1186/s12879-018-3555-1

Table 1.

Baseline characteristics of the study population

Variables Total Baseline Intervention p-value
Patients, n 621 341 280 NA
Male gender, n (%) 370 (59.5) 199 (58.4) 171 (61.1) 0.55
Age (years) 67.56 67.13 68.08 0.43
Total patient days at risk 3171 1613 1558 0.24
Mean length of hospital stay 23.50 21.07 26.46 0.12
Mean length of ICU stay 4.87 4.30 5.40 0.11
Overall mortality, n (%) 85 (13.7) 48 (14.0) 37 (13.7) 0.91
Previous admission Hx. within 3 months, n (%) 139 (22.4) 66 (19.4) 73 (26.1) 0.06
Comorbidities
 Cardiovascular disease, n (%) 453 (72.9) 247 (72.2) 212 (75.2) 0.41
 Diabetes, n (%) 195 (31.4) 111 (32.5) 84 (29.8) 0.49
 Cerebro vascular accident, n (%) 264 (42.5) 146 (42.7) 118 (42.0) 0.87
 Solid organ malignancy, n (%) 75 (12.1) 43 (12.6) 32 (11.3) 0.71
 Hemaologic malignancy, n (%) 4 (0.6) 3(0.9) 1 (0.4) 0.63
 Trauma Hx., n (%) 20 (3.2) 14 (4.1) 6 (2.1) 0.18
 Chronic renal disease, n (%) 133 (21.4) 61 (18.1) 72 (25.5) 0.03
 Chronic liver disease, n (%) 70 (11.3) 36 (10.5) 34 (12.1) 0.61
 Chronic lung disease, n (%) 82 (13.2) 44 (12.9) 38 (13.5) 0.91
 Connective tissue disease, n (%) 13 (2.1) 6 (1.8) 7 (2.5) 0.58
SOFA score 4 (2–7) 4 (2–7) 4 (2–6) 0.38
Invasive procedure
 Central line catheter insertion, n (%) 273 (44.0) 155 (45.3) 118 (41.8) 0.42
 Intubation, n (%) 167 (26.9) 98 (28.7) 69 (24.5) 0.28
 CRRTx.,n (%) 38 (6.1) 22 (6.4) 16 (5.7) 0.74
 Operation history, n (%) 92 (14.8) 51 (15.0) 41 (14.6) 1.00
Median duration of antibiotics treatment 6 (0–15) 7 (0–15) 6 (0–16) 0.59
Vancomycin use, n (%) 70 (11.3) 36 (10.6) 34 (12.1) 0.61
MRSA acquisition prior to ICU admission 57 (9.2) 36 (10.5) 21 (7.5) 0.21
ICU bed occupancy, % 82.0 83.7 81.5 0.22
Hand hygiene compliance of all HCW 72.1 71.6 72.7 0.62
 Hand hygiene compliance of physicians 54.2 53.8 54.6 0.48
 Hand hygiene compliance of nurses 89.9 89.4 90.5 0.64

Data are expressed as the mea / median (Q1-Q3) or N (%)

Abbreviation: NA not applicable, ICU intensive care unit, SOFA sequential organ failure assessment, CRRTx., continuous renal replacement therapy, HCW health care workers